Hereditary breast cancer in sub-Saharan Africa

Current Women's Health Reviews

Volumn 8, Issue 1, 2012, Pages 44-54

  Awadelkarim, Khalid Dafaallah ^a   Elhaj, Ahmed ^a   Aceto, Gitana ^b   Mariani Costantini, Renato ^b   Eltayeb, Elgaylani Abdalla ^a  

^a UNIVERSITY OF GEZIRA   (Sudan)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

BRCA1; BRCA2; Early onset; Genetics; Hereditary breast cancer; Pathology; Sub saharan africa; Sudan

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CYTOCHROME P450 1A1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; LEPTIN; PROTEIN MLH1;

AFRICA; AFRICAN AMERICAN; ANTIBODY RESPONSE; AUTOPSY; BOTTLENECK POPULATION; BREAST CANCER; BREAST SURGERY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER GENETICS; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CAUCASIAN; COBALT TELETHERAPY; DELAYED DIAGNOSIS; EARLY DIAGNOSIS; ETHNICITY; FAMILIAL CANCER; FAMILY HISTORY; FERTILITY; GENETIC VARIABILITY; HEALTH CARE COST; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; KOREA; LIFE EXPECTANCY; LIFESTYLE; MALARIA; MARRIAGE; MIGRATION; MOUSE MAMMARY TUMOR ONCOVIRUS; ONSET AGE; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL STATUS; TUMOR VOLUME; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS;

EID: 84858322266     PISSN: 15734048     EISSN: 18756581     Source Type: Journal    
DOI: 10.2174/157340412799079219     Document Type: Review

References (131)

1. Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G. Breast cancer. Lancet 2005; 365(9472): 1727-1741.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55(2): 74-108.
3. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. Lyon: IARC Press; 2004.
4. Ursin G, Bernstein L, Wang Y, et al. Reproductive factors and risk of breast carcinoma in a study of white and African-American women. Cancer 2004; 101(2): 353-362.
5. Clavel-Chapelon F. Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. Br J Cancer 2002; 86(5): 723-727.
6. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993; 15(1): 36-47.
7. Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 2005; 97(6): 439-448.
8. Pathak DR, Osuch JR, He J. Breast carcinoma etiology: current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations. Cancer 2000; 88(5 Suppl): 1230-1238.
9. Hanby AM. Aspects of molecular phenotype and its correlations with breast cancer behaviour and taxonomy. Br J Cancer 2005; 92(4): 613-617.
10. Igene H. Global health inequalities and breast cancer: an impending public health problem for developing countries. Breast J 2008; 14(5): 428-434.
11. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 2004; 6(6): 229-239.
12. Parkin DM, Ferlay J, Hamdi-Cherif M, et al. Cancer in Africa: Epidemiology and prevention. Lyon: IARC Press; 2003.
13. Parkin DM, Muir CS. Cancer Incidence in Five Continents. Comparability and quality of data. IARC Sci Publ 1992; (120): 45-173.
14. Sighoko D, Bah E, Haukka J, et al. Population-based breast (female) and cervix cancer rates in the Gambia: evidence of ethnicity-related variations. Int J Cancer 2010; 127(10): 2248-2256.
15. Huo D, Adebamowo CA, Ogundiran TO, et al. Parity and breastfeeding are protective against breast cancer in Nigerian women. Br J Cancer 2008; 98(5): 992-996.
16. Enger SM, Ross RK, Henderson B, Bernstein L. Breastfeeding history, pregnancy experience and risk of breast cancer. Br J Cancer 1997; 76(1): 118-123.
17. Basro S, Apffelstaedt JP. Breast cancer in young women in a limited-resource environment. World J Surg 2010; 34(7): 1427-1433.
18. Baltogiannis G, Roukos DH. Letter to the editor: Breast cancer in young women in Africa: are there genetic and clinical differences with European ancestry patients? World J Surg 2010; 34(8): 1982-1983.
19. Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2007, http://seer.cancer.gov/csr/1975_2007/. Bethesda, MD: National Cancer Institute; 2010 April 15, 2010.
20. Vorobiof DA, Sitas F, Vorobiof G. Breast cancer incidence in South Africa. J Clin Oncol 2001; 19(18 Suppl): 125S-127S.
21. Amir H, Kwesigabo G, Aziz MR, Kitinya JN. Breast cancer and conservative surgery in sub Saharan Africa. East Afr Med J 1996; 73(2): 83-87.
22. Adesunkanmi AR, Lawal OO, Adelusola KA, Durosimi MA. The severity, outcome and challenges of breast cancer in Nigeria. Breast 2006; 15(3): 399-409.
23. Gondos A, Brenner H, Wabinga H, Parkin DM. Cancer survival in Kampala, Uganda. Br J Cancer 2005; 92(9): 1808-1812.
24. Ikpatt OF, Kuopio T, Ndoma-Egba R, Collan Y. Breast cancer in Nigeria and Finland: epidemiological, clinical and histological comparison. Anticancer Res 2002; 22(5): 3005-3012.
25. Morris K. Cancer? In Africa? Lancet Oncol 2003; 4(1): 5.
26. Kerr F, Kerr D. Do we bear any moral responsibility for improving cancer care in Africa? Ann Oncol 2006; 17(12): 1730-1731.
27. Parkin DM, Nambooze S, Wabwire-Mangen F, Wabinga HR. Changing cancer incidence in Kampala, Uganda, 1991-2006. Int J Cancer; 126(5): 1187-1195.
28. Gondos A, Chokunonga E, Brenner H, et al. Cancer survival in a southern African urban population. Int J Cancer 2004; 112(5): 860-864.
29. Porter P. Westernizing women's risks? Breast cancer in lowerincome countries. N Engl J Med 2008; 358(3): 213-216.
30. Ekortarl A, Ndom P, Sacks A. A study of patients who appear with far advanced cancer at Yaounde General Hospital, Cameroon, Africa. Psychooncology 2007; 16(3): 255-257.
31. Nyagol J, Nyong'o A, Byakika B, et al. Routine assessment of hormonal receptor and her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer. Anal Quant Cytol Histol 2006; 28(2): 97-103.
32. Oluwatosin OA. Rural women's perception of breast cancer and its early-detection measures in Ibadan, Nigeria. Cancer Nurs 2006; 29(6): 461-466.
33. Dye TD, Bogale S, Hobden C, et al. Complex care systems in developing countries: breast cancer patient navigation in Ethiopia. Cancer; 116(3): 577-585.
34. Fregene A, Newman LA. Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African-American women? Cancer 2005; 103(8):1540-1550.
35. Ijaduola TG, Smith EB. Pattern of breast cancer among white- American, African-American, and nonimmigrant west-African women. J Natl Med Assoc 1998; 90(9): 547-551.
36. Mbonde MP, Amir H, Mbembati NA, et al. Characterisation of benign lesions and carcinomas of the female breast in a sub-Saharan African population. Pathol Res Pract 1998; 194(9): 623-629.
37. Huo D, Ikpatt F, Khramtsov A, et al. Population differences in breast cancer: survey in indigenous African women reveals overrepresentation of triple-negative breast cancer. J Clin Oncol 2009; 27(27): 4515-4521.
38. Okobia MN, Bunker CH. Epidemiological risk factors for breast cancer--a review. Niger J Clin Pract 2005; 8(9):35-42.
39. Okobia M, Bunker C, Zmuda J, et al. Case-control study of risk factors for breast cancer in Nigerian women. Int J Cancer 2006; 119(9): 2179-2185.
40. Gelbard A. Population 101. A primer. Popul Today 1997; 25(9): 4-5.
41. Awadelkarim KD, Arizzi C, Elamin EO, et al. Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa. Histopathology 2008; 52(4): 445-456.
42. Awadelkarim KD, Aceto G, Veschi S, et al. BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors. Breast Cancer Res Treat 2007; 102(2): 189-199.
43. Collaborative Groupon Hormonal Factorsin Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002; 360(9328): 187-195.
44. Medina D. Mammary developmental fate and breast cancer risk. Endocr Relat Cancer 2005; 12(3): 483-495.
45. Russo J, Moral R, Balogh GA, Mailo D, Russo IH. The protective role of pregnancy in breast cancer. Breast Cancer Res 2005; 7(3): 131-142.
46. Odida M, Schmauz R, Lwanga SK. Grade of malignancy of cervical cancer in regions of Uganda with varying malarial endemicity. Int J Cancer 2002; 99(5): 737-741.
47. Dutz W. Immune modulation and disease patterns in population groups. Med Hypotheses 1975; 1(6): 197-203.
48. Fina F, Romain S, Ouafik L, et al. Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br J Cancer 2001; 84(6): 783-790.
49. Stefoni S, Scolari MP, Sestigiani E, et al. [Renal transplantation and malignancies: A single-centre experience (25 years)]. G Ital Nefrol 2002; 19(6): 650-657.
50. Herrmann K, Niedobitek G. Epstein-Barr virus-associated carcinomas: facts and fiction. J Pathol 2003; 199(2): 140-145.
51. Bonnet M, Guinebretiere JM, Kremmer E, et al. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 1999; 91(16): 1376-1381.
52. Epstein MA, Achong BG, Barr YM. Virus Particles in Cultured Lymphoblasts from Burkitt's Lymphoma. Lancet 1964; 1(7335): 702-703.
53. Glaser SL, Hsu JL, Gulley ML. Epstein-Barr virus and breast cancer: state of the evidence for viral carcinogenesis. Cancer Epidemiol Biomarkers Prev 2004; 13(5): 688-697.
54. Liu Y, Klimberg VS, Andrews NR, et al. Human papillomavirus DNA is present in a subset of unselected breast cancers. J Hum Virol 2001; 4(6): 329-334.
55. Pagano JS, Blaser M, Buendia MA, et al. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 2004; 14(6): 453-471.
56. Band V, Zajchowski D, Kulesa V, Sager R. Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci U S A 1990; 87(1): 463-467.
57. Damin AP, Karam R, Zettler CG, Caleffi M, Alexandre CO. Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat 2004; 84(2): 131-137.
58. Di Lonardo A, Venuti A, Marcante ML. Human papillomavirus in breast cancer. Breast Cancer Res Treat 1992; 21(2): 95-100.
59. Hennig EM, Suo Z, Thoresen S, et al. Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat 1999; 53(2): 121-135.
60. Kroupis C, Markou A, Vourlidis N, Dionyssiou-Asteriou A, Lianidou ES. Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem 2006; 39(7): 727-731.
61. Day NK, Witkin SS, Sarkar NH, et al. Antibodies reactive with murine mammary tumor virus in sera of patients with breast cancer: geographic and family studies. Proc Natl Acad Sci U S A 1981; 78(4): 2483-2487.
62. Levine PH, Mesa-Tejada R, Keydar I, et al. Increased incidence of mouse mammary tumor virus-related antigen in Tunisian patients with breast cancer. Int J Cancer 1984; 33(3): 305-308.
63. 5th Population and Housing Census -2008 Priority Results. Khartoum, Sudan: Central Bureau of Statistics (CBS); 2008.
64. Decaillet F, Mullen PD. Sudan Health Status Report: World Bank/AFTH3; August 2003.
65. Awadelkarim KD, Mohamedani AA, Barberis M. Role of pathology in sub-Saharan Africa: An example from Sudan. Pathology and Laboratory Medicine International 2010; 2: 49-57.
66. Andela VB. Harnessing information and communication technologies to leverage scarce resources for cancer education, research and practice in developing countries. Health Res Policy Syst 2006; 4:1.
67. Aderounmu AO, Egbewale BE, Ojofeitimi EO, et al. Knowledge, attitudes and practices of the educated and non-educated women to cancer of the breast in semi-urban and rural areas of South West, Nigeria. Niger Postgrad Med J 2006; 13(3): 182-188.
68. Errico KM, Rowden D. Experiences of breast cancer survivoradvocates and advocates in countries with limited resources: a shared journey in breast cancer advocacy. Breast J 2006; 12(Suppl 1): S111-S116.
69. Ibrahim NA, Odusanya OO. Knowledge of risk factors, beliefs and practices of female healthcare professionals towards breast cancer in a tertiary institution in Lagos, Nigeria. BMC Cancer 2009; 9: 76.
70. Ukwenya AY, Yusufu LM, Nmadu PT, Garba ES, Ahmed A. Delayed treatment of symptomatic breast cancer: the experience from Kaduna, Nigeria. S Afr J Surg 2008; 46(4): 106-110.
71. Hamad HM. Cancer initiatives in Sudan. Ann Oncol 2006; 17(Suppl 8): viii32-viii36.
72. Ahmed HG, Ali AS, Almobarak A. Frequency of breast cancer among sudanese patients with breast palpable lumps. Indian Journal of Cancer 2010; 47(1): 23-26.
73. Alsheikh AA, Mohammed AA, Eltayeb EA, et al. Gezira Guidelines for Management of Breast Cancer. Wad Medani: Institute of Nuclear Medicine, Molecular Biology & Oncology Now, the National Cancer Institute (NC-UG), University of Gezira, Wad Medani, Sudan; 2006.
74. INMO Annual Report. INMO Annual Report. report. Wad Medani: Information and Research Center, Statistic Unit, Department of Oncology, Institute of Nuclear Medicine Molecular Biology & Oncology (INMO), Wad Medani, Sudan; 2006 2006.
75. INMO Annual Report. INMO Annual Report. report. Wad Medani: Information and Research Center, Statistic Unit, Department of Oncology, Institute of Nuclear Medicine Molecular Biology & Oncology (INMO), Wad Medani, Sudan; 2001.
76. Hidayatalla A, Rahman EA. The Radiation and Isotope Centre, Khartoum, 1967-1984. In: Parkin DM, editor. Cancer Occurrence in Developing Countries Lyon: IARC 1986; Pp. 82-87.
77. Awadelkarim KD, Mariani-Costantini R, Elwali NE. Cancer in the Sudan: An overview of the current status of knowledge on tumor patterns and risk factors. Sci Total Environ 2010; [Epub ahead of print].
78. McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 2000; 321(7261): 624-628.
79. Fackenthal JD, Olopade OI. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 2007; 7(12): 937-948.
80. Szabo CI, King MC. Population genetics of BRCA1 and BRCA2. Am J Hum Genet 1997; 60(5): 1013-1020.
81. Khairy GA, Guraya SY, Ahmed ME, Ahmed MA. Bilateral breast cancer. Incidence, diagnosis and histological patterns. Saudi Med J 2005; 26(4): 612-615.
82. Tay JS, Saha N. Genetic heterogeneity among the Negroid and Arab tribes of the Sudan. Am J Phys Anthropol 1988; 76(2): 211-215.
83. El Moghraby AI. State of the environment in the Sudan. In: McCabe M and Sadler B, editors. UNEP studies of EIA practice in developing countries. In: Geneva: United Nations Environment Programme (UNEP); 2003; pp. 27-36.
84. Marcus JN, Watson P, Page DL, Lynch HT. Pathology and heredity of breast cancer in younger women. J Natl Cancer Inst Monogr 1994; (16): 23-34.
85. Merajver SD, Sabel MS. Inflammatory breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the Breast. Philadelphia: Lippincott Williams and Wilkins; 2004.
86. Anderson WF, Schairer C, Chen BE, Hance KW, Levine PH. Epidemiology of inflammatory breast cancer (IBC). Breast Dis 2005; 22: 9-23.
87. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. Jama 2006; 295(21): 2492-2502.
88. Adebamowo CA, Famooto A, Ogundiran TO, et al. Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 2008; 110(1): 183-188.
89. Cann RL, Stoneking M, Wilson AC. Mitochondrial DNA and human evolution. Nature 1987; 325(6099): 31-36.
90. Excoffier L. Human demographic history: refining the recent African origin model. Curr Opin Genet Dev 2002; 12(6): 675-682.
91. Garrigan D, Hammer MF. Reconstructing human origins in the genomic era. Nat Rev Genet 2006; 7(9): 669-680.
92. Adeyemo AA, Chen G, Chen Y, Rotimi C. Genetic structure in four West African population groups. BMC Genet 2005; 6: 38.
93. Tishkoff SA, Williams SM. Genetic analysis of African populations: human evolution and complex disease. Nat Rev Genet 2002; 3(8): 611-621.
94. Yu N, Chen FC, Ota S, et al. Larger genetic differences within africans than between Africans and Eurasians. Genetics 2002; 161(1): 269-274.
95. Rosenberg NA, Pritchard JK, Weber JL, et al. Genetic structure of human populations. Science 2002; 298(5602):2381-2385.
96. Hedenfalk IA, Ringner M, Trent JM, Borg A. Gene expression in inherited breast cancer. Adv Cancer Res 2002; 84: 1-34.
97. Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265(5181): 2088-2090.
98. Gayther SA, Mangion J, Russell P, et al. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 1997; 15(1): 103-105.
99. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266(5182): 66-71.
100. Narod SA, Feunteun J, Lynch HT, et al. Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 1991; 338(8759): 82-83.
101. Thompson D, Szabo CI, Mangion J, et al. From the Cover: Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. PNAS 2002; 99(2): 827-831.
102. Hall MJ, Reid JE, Burbidge LA, et al. BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 2009; 115(10): 2222-2233.
103. Haffty BG, Choi DH, Goyal S, et al. Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Ann Oncol 2009; 20(10): 1653-1659.
104. Simon MS, Petrucelli N. Hereditary breast and ovarian cancer syndrome: the impact of race on uptake of genetic counseling and testing. Methods Mol Biol 2009; 471: 487-500.
105. Pal T, Vadaparampil S, Betts J, et al. BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies. Genet Test 2008; 12(3): 401-407.
106. Kanaan Y, Kpenu E, Utley K, et al. Inherited BRCA2 mutations in African Americans with breast and/or ovarian cancer: a study of familial and early onset cases. Hum Genet 2003; 113(5): 452-460.
107. Olopade OI, Fackenthal JD, Dunston G, et al. Breast cancer genetics in African Americans. Cancer 2003; 97(1 Suppl): 236-245.
108. Adebamowo CA, Akarolo-Anthony S. Cancer in Africa: opportunities for collaborative research and training. Afr J Med Med Sci 2009; 38 (Suppl 2): 5-13.
109. Mefford HC, Baumbach L, Panguluri RC, et al. Evidence for a BRCA1 founder mutation in families of West African ancestry. Am J Hum Genet 1999; 65(2): 575-578.
110. Gao Q, Neuhausen S, Cummings S, Luce M, Olopade OI. Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer. Am J Hum Genet 1997; 60(5): 1233-1236.
111. Stoppa-Lyonnet D, Laurent-Puig P, Essioux L, et al. BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am J Hum Genet 1997; 60(5): 1021-1030.
112. Zhang B, Fackenthal JD, Niu Q, et al. Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry. Fam Cancer 2009; 8(1): 15-22.
113. Sirugo G, Hennig BJ, Adeyemo AA, et al. Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics. Hum Genet 2008; 123(6): 557-598.
114. Tishkoff SA, Reed FA, Friedlaender FR, et al. The genetic structure and history of Africans and African Americans. Science 2009; 324(5930): 1035-1044.
115. Wagner TM, Hirtenlehner K, Shen P, et al. Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations. Hum Mol Genet 1999; 8(3): 413-423.
116. Reeves MD, Yawitch TM, van der Merwe NC, et al. BRCA1 mutations in South African breast and/or ovarian cancer families: evidence of a novel founder mutation in Afrikaner families. Int J Cancer 2004; 110(5): 677-682.
117. Yawitch TM, van Rensburg EJ, Mertz M, Falkson CI. Absence of commonly recurring BRCA1 mutations in black South African women with breast cancer. S Afr Med J 2000; 90(8): 788.
118. Gao Q, Adebamowo CA, Fackenthal J, et al. Protein truncating BRCA1 and BRCA2 mutations in African women with premenopausal breast cancer. Hum Genet 2000; 107(2): 192-194.
119. Fackenthal JD, Sveen L, Gao Q, et al. Complete allelic analysis ofBRCA1 and BRCA2 variants in young Nigerian breast cancer patients. J Med Genet 2005; 42(3): 276-281.
120. Sluiter M, Mew S, van Rensburg EJ. PALB2 sequence variants in young South African breast cancer patients. Fam Cancer 2009; 8(4): 347-353.
121. Blokhuis MM, Goldberg PA, Pietersen GE, et al. The extracolonic cancer spectrum in females with the common 'South African' hMLH1 c.C1528T mutation. Fam Cancer 2008; 7(3): 191-198.
122. Hoshino S, Hosoi T, Miyao M, et al. Identification of a novel polymorphism of estrogen receptor-alpha gene that is associated with calcium excretion in urine. J Bone Miner Metab 2000; 18(3): 153-157.
123. Vasconcelos A, Medeiros R, Veiga I, et al. Analysis of estrogen receptor polymorphism in codon 325 by PCR-SSCP in breast cancer: association with lymph node metastasis. Breast J 2002; 8(4): 226-229.
124. Hsiao WC, Young KC, Lin SL, Lin PW. Estrogen receptor-alpha polymorphism in a Taiwanese clinical breast cancer population: a case-control study. Breast Cancer Res 2004; 6(3): R180-R186.
125. Siddig A, Mohamed AO, Awad S, et al. Estrogen receptor alpha gene polymorphism and breast cancer. Ann N Y Acad Sci 2008; 1138: 95-107.
126. Xie D, Shu XO, Deng Z, et al. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J Natl Cancer Inst 2000; 92(5): 412-417.
127. Beauclair S, Formento P, Fischel JL, et al. Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity. Ann Oncol 2007; 18(8): 1335-1341.
128. Siddig A, Mohamed AO, Kamal H, et al. HER-2/neu Ile655Val polymorphism and the risk of breast cancer. Ann N Y Acad Sci 2008; 1138: 84-94.
129. Garner CP, Ding YC, John EM, et al. Genetic variation in IGFBP2 and IGFBP5 is associated with breast cancer in populations of African descent. Hum Genet 2008; 123(3): 247-255.
130. Okobia M, Bunker C, Zmuda J, et al. Cytochrome P4501A1 genetic polymorphisms and breast cancer risk in Nigerian women. Breast Cancer Res Treat 2005; 94(3): 285-293.
131. Okobia MN, Bunker CH, Garte SJ, et al. Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study. BMC Cancer 2008; 8: 338.